CSIMarket
 
Sqz Biotechnologies Company  (SQZB)
Other Ticker:  
 
 
Price: $0.0280 $0.00 0.000%
Day's High: $0.028 Week Perf: -44 %
Day's Low: $ 0.03 30 Day Perf: -6.67 %
Volume (M): 0 52 Wk High: $ 1.66
Volume (M$): $ 0 52 Wk Avg: $0.04
Open: $0.03 52 Wk Low: $0.02



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 29
 Employees 43
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) -74
 Capital Exp. (TTM) (Millions $) 0

Sqz Biotechnologies Company
Sqz Biotechnologies is a biotechnology company based in Watertown, Massachusetts. The company specializes in developing cell therapies using a proprietary technology called Cell Squeeze. This technology enables the delivery of various molecules, including nucleic acids, proteins, and small molecules, directly into cells using mechanical compression.

Sqz Biotechnologies aims to revolutionize cell therapies by efficiently engineering immune cells for targeted therapeutic purposes. They have developed a diverse pipeline of cell therapies that target various diseases, including cancer, autoimmune disorders, and infectious diseases. The company's approach focuses on improving the effectiveness and specificity of cell therapies, ultimately leading to better patient outcomes.

Sqz Biotechnologies has established partnerships with several pharmaceutical companies and academic institutions to develop innovative cell therapies. They have also received significant investments and funding to support their research and development efforts. Overall, the company is at the cutting edge of cell engineering and is dedicated to advancing the field of cell therapies for the benefit of patients.


   Company Address: 200 Arsenal Yards Blvd Watertown 2472 MA
   Company Phone Number: 758-8672   Stock Exchange / Ticker: SQZB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DNA   -6.44%    
MRNA   -5.91%    
NVAX   -9.31%    
PSTX   -9.31%    
RGNX        17.71% 
SGMO   -14.2%    
• View Complete Report
   



Sqz Biotechnologies Company

Sqz Biotechnologies Plagued by Weak Revenue in Q3 2023



In the financial time-frame ending September 30, 2023, Sqz Biotechnologies Company reported mixed financial results. While the company experienced a slight increase in the shortfall per share compared to the previous year, revenue remained unchanged. This article aims to interpret these financial results and discuss their potential impact on the company moving forward.
Shortfall per Share:
Sqz Biotechnologies witnessed a rise in the shortfall per share, reaching $-0.80 compared to $-0.77 in the previous year. Additionally, the shortfall grew from $-0.57 per share in the prior quarter. This increase in the shortfall per share might raise concerns among investors and stakeholders. It indicates that the company's expenses exceeded its revenues during this period.

Sqz Biotechnologies Company

SQZ Biotechnologies Company Shows Impressive Recovery with Declining Losses in Q2 2023, but Revenue Plummets



In the April to June 30, 2023 fiscal time-frame, Sqz Biotechnologies Company demonstrated a reduction in losses per share compared to the same period last year. The company reported a loss of $-0.57 per share, down from $-0.78 per share in the previous year. Moreover, the earnings per share (EPS) also improved from -$0.60 per share from the preceding reporting period. These figures indicate a positive trajectory for the company's financial performance.
However, despite these encouraging results, Sqz Biotechnologies Company experienced a drastic decline in revenue during this period. Revenue plummeted by -94.463% to $0.18 million from $3.22 million in the comparable reporting period a year ago. Sequentially, revenue dropped from $0.00 million, indicating a challenging operating environment for the company.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com